The DOI matches its Crossref record; 46 of the 46 references it cites were found in a registry or an index.
Stromal and Epithelial Expression of Tumor Markers Hyaluronic Acid and HYAL1 Hyaluronidase in Prostate Cancer
Open accessAbstract
Hyaluronic acid (HA), a glycosaminoglycan, regulates cell adhesion and migration. Hyaluronidase (HAase), an endoglycosidase, degrades HA into small angiogenic fragments. Using an enzyme-linked immunosorbent assay-like assay, we found increased HA levels (3-8-fold) in prostate cancer (CaP) tissues when compared with normal (NAP) and benign (BPH) tissues. The majority ( approximately 75-80%) of HA in prostate tissues was found to exist in the free form. Primary CaP fibroblast and epithelial cells secreted 3-8-fold more HA than respective NAP and BPH cultures. Only CaP epithelial cells and established CaP lines secreted HAase and the secretion increased with tumor grade and metastasis. The pH activity profile and optimum (4.2; range 4.0-4.3) of CaP HAase was identical to the HYAL1-type HAase present in human serum and urine. Full-length HYAL1 transcript and splice variants were detected in CaP cells by reverse transcriptase-polymerase chain reaction, cloning, and sequencing. Immunoblotting confirmed secretion of a approximately 60-kDa HYAL1-related protein by CaP cells. Immunohistochemistry showed minimal HA and HYAL1 staining in NAP and BPH tissues. However, a stromal and epithelial pattern of HA and HYAL1 expression was observed in CaP tissues. While high HA staining was observed in tumor-associated stroma, HYAL1 staining in tumor cells increased with tumor grade and metastasis. The gel-filtration column profiles of HA species in NAP, BPH, and CaP tissues were different. While the higher molecular mass and intermediate size HA was found in all tissues, the HA fragments were found only in CaP tissues. In particular, the high-grade CaP tissues, which showed both elevated HA and HYAL1 levels, contained angiogenic HA fragments. The stromal-epithelial HA and HYAL1 expression may promote angiogenesis in CaP and may serve as prognostic markers for CaP.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Laurent, T. C., & Fraser, J. R. E. (1992) · The FASEB Journal · doi:10.1096/fasebj.6.7.1563592 · Cited by 1,880
The relevance of tumour pH to the treatment of malignant disease
Wike-Hooley, J. L., Haveman, J., & Reinhold, H. S. (1984) · Radiotherapy and Oncology · doi:10.1016/s0167-8140(84)80077-8 · Cited by 903
Auvinen, P., Tammi, R., Parkkinen, J., Tammi, M., Ågren, U., Johansson, R., Hirvikoski, P., Eskelinen, M., & Kosma, V.-M. (2000) · The American Journal of Pathology · doi:10.1016/s0002-9440(10)64757-8 · Cited by 493
SERUM PSA AFTER ANATOMIC RADICAL PROSTATECTOMY
Partin, A. W., Pound, C. R., Clemens, J. Q., Epstein, J. I., & Walsh, P. C. (1993) · Urologic Clinics of North America · doi:10.1016/s0094-0143(21)00924-1 · Cited by 460
Physical Properties and Polydispersity of Proteoglycan from Bovine Nasal Cartilage
Hascall, V. C., & Sajdera, S. W. (1970) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(18)62796-6 · Cited by 357
West, D. C., & Kumar, S. (1989) · Experimental Cell Research · doi:10.1016/0014-4827(89)90428-x · Cited by 357
Tumor cell-associated hyaluronan as an unfavorable prognostic factor in colorectal cancer.
Ropponen, K. M., Tammi, M., Parkkinen, J. J., Eskelinen, M., Tammi, R., Lipponen, P., Ågren, U. M., ALHAVA, E. M., & Kosma, V. (1998) · PubMed · Cited by 327
Lepperdinger, G., Strobl, B., & Kreil, G. (1998) · Journal of Biological Chemistry · doi:10.1074/jbc.273.35.22466 · Cited by 300
Tengblad, A. (1979) · Biochimica et Biophysica Acta (BBA) - Protein Structure · doi:10.1016/0005-2795(79)90158-2 · Cited by 261
Csóka, A. B., Scherer, S. W., & Stern, R. (1999) · Genomics · doi:10.1006/geno.1999.5876 · Cited by 255
Cited by
Hyaluronan: from extracellular glue to pericellular cue
Toole, B. P. (2004) · Nature Reviews Cancer · doi:10.1038/nrc1391 · Cited by 2,125
Hyaluronic Acid in the Third Millennium
Fallacara, A., Baldini, E., Manfredini, S., & Vertuani, S. (2018) · Polymers · doi:10.3390/polym10070701 · Cited by 860
Hyaluronic acid-based hydrogels: from a natural polysaccharide to complex networks
Xu, X., Jha, A. K., Harrington, D. A., Farach-Carson, M. C., & Jia, X. (2012) · Soft Matter · doi:10.1039/c2sm06463d · Cited by 601
Three-dimensional in vitro tumor models for cancer research and drug evaluation
Xu, X., Farach-Carson, M. C., & Jia, X. (2014) · Biotechnology Advances · doi:10.1016/j.biotechadv.2014.07.009 · Cited by 461
Slevin, M., Krupinski, J., Gaffney, J., Matou, S., West, D., Delisser, H., Savani, R. C., & Kumar, S. (2007) · Matrix Biology · doi:10.1016/j.matbio.2006.08.261 · Cited by 432
Bladder tumor markers beyond cytology: International Consensus Panel on bladder tumor markers
Lokeshwar, V. B., Habuchi, T., Grossman, H. B., Murphy, W. M., Hautmann, S. H., Hemstreet, G. P., Bono, A. V., Getzenberg, R. H., Goebell, P., Schmitz-Dräger, B. J., et al. (2005) · Urology · doi:10.1016/j.urology.2005.08.064 · Cited by 431
Self-citationHeme Oxygenase-1 in Tumors: Is It a False Friend?
Jozkowicz, A., Was, H., & Dulak, J. (2007) · Antioxidants & Redox Signaling · doi:10.1089/ars.2007.1659 · Cited by 382
Development and application of hyaluronic acid in tumor targeting drug delivery
Luo, Z., Dai, Y., & Gao, H. (2019) · Acta Pharmaceutica Sinica B · doi:10.1016/j.apsb.2019.06.004 · Cited by 379
Cancer‐Associated, Stimuli‐Driven, Turn on Theranostics for Multimodality Imaging and Therapy
Li, X., Kim, J., Yoon, J., & Chen, X. (2017) · Advanced Materials · doi:10.1002/adma.201606857 · Cited by 362
The Content and Size of Hyaluronan in Biological Fluids and Tissues
Cowman, M. K., Lee, H.-G., Schwertfeger, K. L., McCarthy, J. B., & Turley, E. A. (2015) · Frontiers in Immunology · doi:10.3389/fimmu.2015.00261 · Cited by 346
Devising a pathway for hyaluronan catabolism: are we there yet?
Stern, R. (2003) · Glycobiology · doi:10.1093/glycob/cwg112 · Cited by 337
Marine Origin Polysaccharides in Drug Delivery Systems
Cardoso, M., Costa, R., & Mano, J. (2016) · Marine Drugs · doi:10.3390/md14020034 · Cited by 297
Hyaluronan in human malignancies
Sironen, R. K., Tammi, M., Tammi, R., Auvinen, P. K., Anttila, M., & Kosma, V.-M. (2011) · Experimental Cell Research · doi:10.1016/j.yexcr.2010.11.017 · Cited by 294
Design of cell–matrix interactions in hyaluronic acid hydrogel scaffolds
Lam, J., Truong, N. F., & Segura, T. (2014) · Acta Biomaterialia · doi:10.1016/j.actbio.2013.07.025 · Cited by 286
Kultti, A., Pasonen-Seppänen, S., Jauhiainen, M., Rilla, K. J., Kärnä, R., Pyöriä, E., Tammi, R. H., & Tammi, M. I. (2009) · Experimental Cell Research · doi:10.1016/j.yexcr.2009.03.002 · Cited by 280
Tammi, R. H., Kultti, A., Kosma, V.-M., Pirinen, R., Auvinen, P., & Tammi, M. I. (2008) · Seminars in Cancer Biology · doi:10.1016/j.semcancer.2008.03.005 · Cited by 272
Choi, K. Y., Saravanakumar, G., Park, J. H., & Park, K. (2012) · Colloids and Surfaces B: Biointerfaces · doi:10.1016/j.colsurfb.2011.10.029 · Cited by 264
Emerging Roles for Hyaluronidase in Cancer Metastasis and Therapy
(2014) · Advances in Cancer Research · doi:10.1016/b978-0-12-800092-2.00001-0 · Cited by 204
“HA fragments (20–30-mers) have been detected in high-grade prostate cancer tissues (Lokeshwar et al., 2001) and knockdown of Hyal1 also impairs angiogenesis (Lokeshwar et al., 2005).”
Metadata
- Authors
- Lokeshwar, V. B., Rubinowicz, D., Schroeder, G. L., Forgacs, E., Minna, J. D., Block, N. L., Nadji, M., & Lokeshwar, B. L.
- Venue
- Journal of Biological Chemistry
- Publisher
- Elsevier BV
- Published
- 2001-04
- Volume
- 276
- Issue
- 15
- Pages
- 11922-11932
- ISSN
- 0021-9258 (ISSN-L)
- OpenAlex
- W2048573811
- Cited by
- 303
- References
- 46
- FWCI
- 4.63
- Type
- journal article
- Language
- en
- Open access
- hybrid
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.